Janux Therapeutics Inc.

JANX | NASDAQ

Price Alert Chart Builder DCF Calculator

$17.24

+$0.23 (+1.35%)

Sep 22, 2026, 1:31 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	52.33M	430.61M	19.21M	51.43M	35.58M	7.81M
Short-Term Investments	914.23M	594.57M	324.82M	275.59M	339.38M	n/a
Long-Term Investments	816K	n/a	n/a	816K	n/a	n/a
Other Long-Term Assets	2.61M	3.7M	3.33M	1.39M	1.21M	n/a
Receivables	6.43M	5.38M	2.16M	700K	200K	8M
Inventory	n/a	n/a	n/a	-700K	n/a	n/a
Other Current Assets	n/a	n/a	n/a	5.42M	1.85M	n/a
Total Current Assets	975.89M	1.03B	349.24M	332.44M	377.02M	16.06M
Property-Plant & Equipment	22.25M	24.15M	27.84M	29.37M	1.6M	155K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	31.64M	27.85M	31.17M	31.57M	2.81M	155K
Total Assets	1.01B	1.06B	380.41M	364.01M	379.82M	16.22M
Account Payables	4.97M	4.03M	2.42M	2.16M	2.46M	428K
Deferred Revenue	n/a	n/a	1.71M	5.41M	5.16M	1.95M
Short-Term Debt	2.39M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	13.04M	4.57M	3.3M	5.51M	2.37M	338K
Total Current Liabilities	25M	17.46M	13.03M	16.51M	12.8M	3.18M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	21.62M
Total Long-Term Liabilities	25.7M	21.28M	23.03M	26.76M	700K	27.67M
Total Liabilities	50.7M	38.74M	36.06M	43.27M	13.5M	30.86M
Total Debt	22.14M	23.03M	24.54M	25.31M	194K	n/a
Book Value	956.82M	1.02B	344.35M	320.74M	366.33M	-14.64M
Book Value Per Share	15.44	19.03	7.82	7.73	8.88	-0.35
Common Stock	60K	59K	46K	42K	41K	1K
Retained Earnings	-351.38M	-237.76M	-168.76M	-110.47M	-47.41M	-14.74M
Comprehensive Income	4.32M	2.16M	665K	-1.54M	-270K	n/a
Shareholders Equity	956.82M	1.02B	344.35M	320.74M	366.33M	-14.64M
Total Investments	914.23M	594.57M	324.82M	275.59M	339.38M	n/a